Showing results (151-160 of 174) with videos related to

Sort By:
Pageof 18
Transplantation and Cellular Therapy|February 9, 2022
Improving Safety and Outcomes After Allogeneic Hematopoietic Cell Transplantation: A Single-Center ExperienceMaria Queralt Salas, Ivan Pasic, Mats Remberger, et al.
Leukemia & Lymphoma|July 28, 2020
High incidence but low mortality of EBV-reactivation and PTLD after alloHCT using ATG and PTCy for GVHD prophylaxisMaria Queralt Salas, Shruti Prem, Mats Remberger, et al.
Transplantation and Cellular Therapy|August 14, 2023
Choosing Between Older Matched Sibling Donor and Younger Matched Unrelated Donor in Allogeneic Hematopoietic Cell Transplantation: Comparison of Clinical Outcomes in Acute Myeloid Leukemia and Myelodysplastic SyndromeMariana Pinto Pereira, Mats Remberger, Carol Chen, et al.
Transplantation|March 15, 2006
Allogeneic hematopoietic stem cell transplantation for inherited disorders: experience in a single centerOlle Ringdén, Mats Remberger, Britt-Marie Svahn, et al.
Transplantation and Cellular Therapy|October 30, 2025
Herpes Zoster Frequency and Adjuvanted Recombinant Zoster Vaccination after Allogeneic Hematopoietic Cell TransplantationVictoria G Hall, Caden Chiarello, Mats Remberger, et al.
Transplantation and Cellular Therapy|April 22, 2024
Treosulfan- Versus Busulfan-based Conditioning in Allogeneic Hematopoietic Cell Transplantation for Myelodysplastic Syndrome: A Single-center Retrospective Propensity Score-matched Cohort StudyIvan Pasic, Tommy Alfaro Moya, Mats Remberger, et al.
British Journal of Haematology|July 19, 2025
Impact of graft-versus-host disease prophylaxis on second primary malignancies after allogeneic haematopoietic stem cell transplantationNihar Desai, Eshrak Al-Shaibani, Tommy Alfaro-Moya, et al.
Leukemia|July 28, 2023
WT1 and PRAME RNA-loaded dendritic cell vaccine as maintenance therapy in de novo AML after intensive induction chemotherapyYngvar Fløisand, Mats Remberger, Iris Bigalke, et al.
Transplantation and Cellular Therapy|October 17, 2021
Bloodstream Infections and Outcomes Following Allogeneic Hematopoietic Cell Transplantation: A Single-Center StudyAbel Santos Carreira, Maria Queralt Salas, Mats Remberger, et al.
Bone Marrow Transplantation|June 3, 2025
Prolonged length of stay in high-risk patients undergoing allogeneic stem cell transplantation: a call to action for addressing healthcare challengesAyman Sayyed, Igor Novitzky-Basso, Mats Remberger, et al.
Pageof 18